Clinical Trial Update: Trial of Tolcapone With Oxaliplatin for Neuroblastoma [Phase 1]

View source ↗

Summary

This update indicates that a Phase 1 trial of tolcapone in combination with oxaliplatin for neuroblastoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Drugs mentioned

• Eloxatin (oxaliplatin)
• Tasmar (tolcapone)

Snippet

Sponsor: Giselle Sholler | Conditions: Neuroblastoma | Phase 1 | Status: TERMINATED